Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference152 articles.
1. Capodanno, D., Alfonso, F., Levine, G. N., Valgimigli, M. & Angiolillo, D. J. ACC/AHA versus ESC Guidelines on dual antiplatelet therapy. J. Am. Coll. Cardiol. 72, 2915–2931 (2018).
2. Capodanno, D. et al. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease. Nat. Rev. Cardiol. 17, 242–257 (2020).
3. Knuuti, J. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 41, 407–477 (2020).
4. Costa, F. et al. Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting. J. Am. Coll. Cardiol. 73, 741–754 (2019).
5. Valgimigli, M. et al. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. Eur. Heart J. 38, 804–810 (2017).
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献